Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographic data on patients and healthy controls

From: Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study

  AAV (N = 86) MPO-ANCA (N = 42) PR3-ANCA (N = 44) HC (N = 69)
Age (years)* 62.2 ± 13.5 65.9 ± 10.9 59.7 ± 15.2 40.4 ± 9.8
Male gender (%) 69 64 73 59
  1. AAV, ANCA-associated vasculitis; MPO-ANCA, antineutrophil cytoplasmic antibodies against myeloperoxidase; PR3-ANCA, ANCA against proteinase 3; HC, healthy controls
  2. * Mean ± standard deviation